ID   HPSE_RAT                Reviewed;         536 AA.
AC   Q71RP1; Q9QZF8;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 109.
DE   RecName: Full=Heparanase;
DE            EC=3.2.1.166;
DE   AltName: Full=Endo-glucoronidase;
DE   Contains:
DE     RecName: Full=Heparanase 8 kDa subunit;
DE   Contains:
DE     RecName: Full=Heparanase 50 kDa subunit;
DE   Flags: Precursor;
GN   Name=Hpse; Synonyms=Hep;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=10395326; DOI=10.1038/10525;
RA   Hulett M.D., Freeman C., Hamdorf B.J., Baker R.T., Harris M.J.,
RA   Parish C.R.;
RT   "Cloning of mammalian heparanase, an important enzyme in tumor invasion and
RT   metastasis.";
RL   Nat. Med. 5:803-809(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ACTIVITY REGULATION.
RX   PubMed=12077130; DOI=10.1074/jbc.m203282200;
RA   Podyma-Inoue K.A., Yokote H., Sakaguchi K., Ikuta M., Yanagishita M.;
RT   "Characterization of heparanase from a rat parathyroid cell line.";
RL   J. Biol. Chem. 277:32459-32465(2002).
RN   [3]
RP   FUNCTION.
RX   PubMed=15677344; DOI=10.1096/fj.04-1970com;
RA   Zcharia E., Zilka R., Yaar A., Yacoby-Zeevi O., Zetser A., Metzger S.,
RA   Sarid R., Naggi A., Casu B., Ilan N., Vlodavsky I., Abramovitch R.;
RT   "Heparanase accelerates wound angiogenesis and wound healing in mouse and
RT   rat models.";
RL   FASEB J. 19:211-221(2005).
CC   -!- FUNCTION: Endoglycosidase that cleaves heparan sulfate proteoglycans
CC       (HSPGs) into heparan sulfate side chains and core proteoglycans.
CC       Participates in extracellular matrix (ECM) degradation and remodeling.
CC       Selectively cleaves the linkage between a glucuronic acid unit and an
CC       N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo
CC       group. Can also cleave the linkage between a glucuronic acid unit and
CC       an N-sulfo glucosamine unit carrying a 2-O-sulfo group, but not
CC       linkages between a glucuronic acid unit and a 2-O-sulfated iduronic
CC       acid moiety. It is essentially inactive at neutral pH but becomes
CC       active under acidic conditions such as during tumor invasion and in
CC       inflammatory processes. Facilitates cell migration associated with
CC       metastasis, wound healing and inflammation. Enhances shedding of
CC       syndecans, and increases endothelial invasion and angiogenesis in
CC       myelomas. Acts as a procoagulant by increasing the generation of
CC       activation factor X in the presence of tissue factor and activation
CC       factor VII. Increases cell adhesion to the extracellular matrix (ECM),
CC       independent of its enzymatic activity. Induces AKT1/PKB phosphorylation
CC       via lipid rafts increasing cell mobility and invasion. Heparin
CC       increases this AKT1/PKB activation. Regulates osteogenesis. Enhances
CC       angiogenesis through up-regulation of SRC-mediated activation of VEGF.
CC       Implicated in hair follicle inner root sheath differentiation and hair
CC       homeostasis (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:15677344}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=endohydrolysis of (1->4)-beta-D-glycosidic bonds of heparan
CC         sulfate chains in heparan sulfate proteoglycan.; EC=3.2.1.166;
CC   -!- ACTIVITY REGULATION: Inhibited by laminarin sulfate and, to a lower
CC       extent, by heparin and sulfamin (By similarity). Activated by calcium
CC       and magnesium. Inhibited by EDTA. {ECO:0000250,
CC       ECO:0000269|PubMed:12077130}.
CC   -!- SUBUNIT: Heterodimer; heterodimer formation between the 8 kDa and the
CC       50 kDa subunits is required for enzyme activity (By similarity).
CC       Interacts with TF; the interaction, inhibited by heparin, enhances the
CC       generation of activated factor X and activates coagulation. Interacts
CC       with HRG; the interaction is enhanced at acidic pH, partially inhibits
CC       binding of HPSE to cell surface receptors and modulates its enzymatic
CC       activity. Interacts with SDC1; the interaction enhances the shedding of
CC       SDC1. Interacts with HPSE2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Lysosome membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Secreted {ECO:0000250}. Nucleus
CC       {ECO:0000250}. Note=Proheparanase is secreted via vesicles of the
CC       Golgi. Interacts with cell membrane heparan sulfate proteoglycans
CC       (HSPGs). Endocytosed and accumulates in endosomes. Transferred to
CC       lysosomes where it is proteolytically cleaved to produce the active
CC       enzyme. Under certain stimuli, transferred to the cell surface.
CC       Colocalizes with SDC1 in endosomal/lysosomal vesicles. Accumulates in
CC       perinuclear lysosomal vesicles. Heparin retains proheparanase in the
CC       extracellular medium. Associates with lipid rafts (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Proteolytically processed. The cleavage of the 65 kDa form leads
CC       to the generation of a linker peptide, and the 8 kDa and 50 kDa
CC       products. The active form, the 8/50 kDa heterodimer, is resistant to
CC       degradation. Complete removal of the linker peptide appears to be a
CC       prerequisite to the complete activation of the enzyme (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: N-glycosylated. Glycosylation of the 50 kDa subunit appears to be
CC       essential for its solubility (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 79 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF359508; AAQ15189.1; -; mRNA.
DR   EMBL; AF184967; AAF04563.1; -; mRNA.
DR   RefSeq; NP_072127.1; NM_022605.1.
DR   AlphaFoldDB; Q71RP1; -.
DR   SMR; Q71RP1; -.
DR   STRING; 10116.ENSRNOP00000002983; -.
DR   CAZy; GH79; Glycoside Hydrolase Family 79.
DR   GlyCosmos; Q71RP1; 4 sites, No reported glycans.
DR   GlyGen; Q71RP1; 4 sites.
DR   PhosphoSitePlus; Q71RP1; -.
DR   PaxDb; 10116-ENSRNOP00000002983; -.
DR   GeneID; 64537; -.
DR   KEGG; rno:64537; -.
DR   AGR; RGD:61969; -.
DR   CTD; 10855; -.
DR   RGD; 61969; Hpse.
DR   eggNOG; ENOG502QQST; Eukaryota.
DR   InParanoid; Q71RP1; -.
DR   OrthoDB; 1054039at2759; -.
DR   PhylomeDB; Q71RP1; -.
DR   Reactome; R-RNO-2024096; HS-GAG degradation.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:Q71RP1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:1904974; C:heparanase complex; ISO:RGD.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0030305; F:heparanase activity; IDA:RGD.
DR   GO; GO:0045545; F:syndecan binding; ISO:RGD.
DR   GO; GO:0060055; P:angiogenesis involved in wound healing; ISO:RGD.
DR   GO; GO:0007160; P:cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0061028; P:establishment of endothelial barrier; ISO:RGD.
DR   GO; GO:0030200; P:heparan sulfate proteoglycan catabolic process; ISS:UniProtKB.
DR   GO; GO:0030202; P:heparin metabolic process; ISO:RGD.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0051798; P:positive regulation of hair follicle development; ISO:RGD.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISO:RGD.
DR   GO; GO:0071806; P:protein transmembrane transport; ISO:RGD.
DR   GO; GO:0051797; P:regulation of hair follicle development; ISO:RGD.
DR   GO; GO:0061042; P:vascular wound healing; ISO:RGD.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   Gene3D; 3.20.20.80; Glycosidases; 1.
DR   InterPro; IPR005199; Glyco_hydro_79.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR46145; HEPARANASE; 1.
DR   PANTHER; PTHR46145:SF3; HEPARANASE; 1.
DR   Pfam; PF03662; Glyco_hydro_79n; 1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
PE   2: Evidence at transcript level;
KW   Calcium; Cell adhesion; Disulfide bond; Glycoprotein; Hydrolase; Lysosome;
KW   Magnesium; Membrane; Nucleus; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000250"
FT   CHAIN           29..102
FT                   /note="Heparanase 8 kDa subunit"
FT                   /id="PRO_0000042266"
FT   PROPEP          103..150
FT                   /note="Linker peptide"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000042267"
FT   CHAIN           151..536
FT                   /note="Heparanase 50 kDa subunit"
FT                   /id="PRO_0000042268"
FT   REGION          281..410
FT                   /note="Required for heterodimerization with the heparanase
FT                   8 kDa subunit"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   REGION          520..536
FT                   /note="Required for transferring proheparanase to the Golgi
FT                   apparatus, secretion and subsequent enzyme activity and for
FT                   enhancement of PKB/AKT1 phosphorylation"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   ACT_SITE        218
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   ACT_SITE        336
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         55..57
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         90
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         151..155
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         263..273
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         289
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         296
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         341..343
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   BINDING         382..384
FT                   /ligand="heparan sulfate group"
FT                   /ligand_id="ChEBI:CHEBI:157750"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        155
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        193
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        210
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CARBOHYD        452
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   DISULFID        120..172
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   DISULFID        430..535
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y251"
FT   CONFLICT        15
FT                   /note="G -> R (in Ref. 2; AAF04563)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227
FT                   /note="H -> Q (in Ref. 2; AAF04563)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        350
FT                   /note="D -> N (in Ref. 2; AAF04563)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   536 AA;  60480 MW;  C434E04CF536EA4D CRC64;
     MLRPLLLLWL WGRLGALTQG TPAGTAPTKD VVDLEFYTKR LFQSVSPSFL SITIDASLAT
     DPRFLTFLGS PRLRALARGL SPAYLRFGGT KTDFLIFDPN KEPTSEERSY WQSQDNNDIC
     GSERVSADVL RKLQMEWPFQ ELLLLREQYQ REFKNSTYSR SSVDMLYSFA KCSRLDLIFG
     LNALLRTPDL RWNSSNAQLL LNYCSSKGYN ISWELGNEPN SFWKKAHISI DGLQLGEDFV
     ELHKLLQKSA FQNAKLYGPD IGQPRGKTVK LLRSFLKAGG EVIDSLTWHH YYLNGRVATK
     EDFLSSDVLD TFILSVQKIL KVTKEMTPGK KVWLGETSSA YGGGAPLLSD TFAAGFMWLD
     KLGLSAQLGI EVVMRQVFFG AGNYHLVDEN FEPLPDYWLS LLFKKLVGPK VLMSRVKGPD
     RSKLRVYLHC TNVYHPRYRE GDLTLYVLNL HNVTKHLKLP PPMFSRPVDK YLLKPFGSDG
     LLSKSVQLNG QTLKMVDEQT LPALTEKPLP AGSSLSVPAF SYGFFVIRNA KIAACI
//
